DALIMZO Trademark

Trademark Overview

On Tuesday, March 24, 2015, a trademark application was filed for DALIMZO with the United States Patent and Trademark Office. The USPTO has given the DALIMZO trademark a serial number of 86574245. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2019. This trademark is owned by Novartis AG. The DALIMZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, analgesics, anti-inflammatory drugs and antipyretics
dalimzo

General Information

Serial Number86574245
Word MarkDALIMZO
Filing DateTuesday, March 24, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, analgesics, anti-inflammatory drugs and antipyretics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, April 1, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 1, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 11, 2018EXTENSION 5 GRANTED
Friday, August 31, 2018EXTENSION 5 FILED
Tuesday, September 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 31, 2018TEAS EXTENSION RECEIVED
Thursday, March 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2018EXTENSION 4 GRANTED
Tuesday, February 27, 2018EXTENSION 4 FILED
Tuesday, February 27, 2018TEAS EXTENSION RECEIVED
Thursday, August 31, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 29, 2017EXTENSION 3 GRANTED
Tuesday, August 29, 2017EXTENSION 3 FILED
Tuesday, August 29, 2017TEAS EXTENSION RECEIVED
Tuesday, February 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, February 26, 2017EXTENSION 2 GRANTED
Sunday, February 26, 2017EXTENSION 2 FILED
Sunday, February 26, 2017TEAS EXTENSION RECEIVED
Thursday, September 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 30, 2016EXTENSION 1 GRANTED
Tuesday, August 30, 2016EXTENSION 1 FILED
Tuesday, August 30, 2016TEAS EXTENSION RECEIVED
Tuesday, March 1, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 19, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NON-FINAL ACTION WRITTEN
Monday, April 20, 2015ASSIGNED TO EXAMINER
Wednesday, April 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 27, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

dalimzo inflammatory drugs antipyretics anti analgesics preparations human namely pharmaceutical